Policies & Reports
Payments to healthcare professionals
card, titleone-fs-32px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-general-third-parties, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Payments to healthcare organisations
card, titleone-fs-32px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-general-third-parties, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Collaborative working projects with the NHS
card, titleone-fs-32px, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
2025 gender pay gap report
card, titleone-fs-32px, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Payments to patient organisations
card, titleone-fs-32px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-uk, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Modern slavery act transparency statement
card, titleone-fs-32px, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Our taxation principles
card, titleone-fs-32px, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
card, ctatarget-sametab, ctaexitinterstitial-select, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
additional-link, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select
additional-link, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select
additional-link, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select
Our taxation principles
Eli Lilly and Company and its subsidiaries around the world (“Lilly”) pay a significant amount of taxes to local, state, provincial, regional and national governments including taxes on profits, social taxes on employment, taxes on property, excise taxes on purchases, customs and duties, withholding taxes, environmental and other taxes. In addition, our businesses collect sales and value added taxes and other similar transactional taxes charged to our customers. We also collect numerous taxes paid by our employees. Lilly pays all taxes due in full and on time in the geographic jurisdictions in which we operate.
The principles guiding Lilly’s global tax affairs consist of the following:
The principles guiding Lilly’s global tax affairs consist of the following:
Tax compliance:
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
- Lilly is committed to complying with all applicable tax laws, rules, regulations and related disclosure requirements and will pay the correct amount of tax due based on such tax laws, rules and regulations of the jurisdictions in which we operate.
- Lilly will interpret applicable tax laws using relevant guidance and apply diligent professional care and judgment to arrive at well-reasoned conclusions, including discussing such conclusions with tax authorities where appropriate.
- Lilly will seek certainty in its tax conclusions but, where tax law is unclear or subject to interpretation, written advice will be sought as appropriate to understand and minimise risk.
- Lilly will ensure all material tax-related conclusions are made at the appropriate level and supported with documentation that evidences the facts, determinations and risks involved.
- Lilly’s tax risk is integrated within the Company’s enterprise risk management and compliance framework.
Tax management:
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
- Lilly will manage its tax affairs efficiently to reduce uncertainty, enhance shareholder value, and maintain global competitiveness, always guided by our Lilly brand and business integrity.
- Lilly will comply with the tax laws of the countries in which it operates including claiming properly available allowances, deductions, reliefs, incentives, exemptions and credits where it is beneficial and appropriate to do so.
- Lilly aligns its tax affairs with its commercial investments and business strategies with significant tax risks overseen within the Company’s enterprise risk management and compliance framework.
Tax relationships:
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
- Lilly will seek to have open and constructive working relationships with tax authorities and government bodies, all based upon our Lilly values of integrity, excellence, and respect for people to minimise disputes and risks.
- Lilly will, where appropriate, enter into continuous audit programmes and agreements to enhance certainty on the tax treatment of our business.
Directors' duties under section 172 of the Companies Act
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
The directors of Eli Lilly and Company Limited consider, both individually and together, that they have acted in the way they consider, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole having regard to the stakeholders and matters set out in s172(1)(a-f) of the Companies Act. The decisions made by the company during the year ending 31 December 2024 have been made with the objective: to have a long-term beneficial impact on the company, to engage employees with equality and with their interests, to develop strong value-adding business relationships with the company's stakeholders, to take into account the wider impact of the company's actions on the environment and to be ethical and maintain the high levels of business conduct.
The Directors are fully aware of their responsibilities to promote the success of the company in accordance with section 172 of the Companies Act 2006. To ensure the company is operating in line with good corporate practice, a written reminder of the section 172 duty is included on each Board agenda.
The Directors are fully aware of their responsibilities to promote the success of the company in accordance with section 172 of the Companies Act 2006. To ensure the company is operating in line with good corporate practice, a written reminder of the section 172 duty is included on each Board agenda.
Engaging with our employees
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
Eli Lilly and Company Limited’s purpose is to make life better for people around the world. To do this, the company must attract, engage, and retain highly talented individuals who are committed to the same core values of integrity, excellence, and respect for people. To support the company’s strategy Lilly has begun creating a culture globally that emphasises four key behaviours - include, innovate, accelerate and deliver - so that the company’s employees feel like they are part of one Team Lilly with one purpose; to make life better for patients who are waiting. The directors of Eli Lilly and Company Limited continue to maintain and develop its policy of involving and communicating with its employees as explained more fully in the company's 2024 Directors' report set out on page 12 of the financial statement.
Engaging with our customers
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
The company remains committed to providing its customers with innovative medicines, information and exceptional customer service, to support people to live healthier and more active lives.
Engaging with our suppliers
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
The company is committed to ensuring it works responsibly with suppliers. During the year, the Board reviewed and approved the company’s Modern Slavery and Human Trafficking Statement, which sets out the steps taken to prevent modern slavery in the company’s business and supply chains. The Company has enacted a Supplier Code of Conduct with which both its existing and new suppliers are contractually obliged to adhere, it has introduced new measures to effectively vet potential new suppliers for compliance with modern slavery requirements, and it is committed to providing tailored training on anti-slavery and human trafficking requirements and awareness to its key staff.
Engaging with our shareholders
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
The Board is committed to openly engaging with the company’s shareholders as they recognise the importance of effective communication, visibility of strategy and objectives and tackling industry risks proactively.
The impact of the company’s operations on the community and environment
accordion-item, title-fs-24px, titlestyle-standardtitle, layout-1column, description-fs-16px
In a challenging, research-based pharmaceutical industry, the company is committed to making high-quality medicines responsibly. The company aims to achieve world-class performance by operating safely, minimising use of natural resources, and lessening the company’s impact on the environment. The company actively promotes waste recycling, encourages green travel and continues to invest in the local communities in which Eli Lilly and Company Limited operates. The Directors fully support and encourage employees to take part in a wide range of programmes to help the company meet this commitment.